News

Article

Custom Pharma Services Expands Manufacturing and Development Operations

The CDMO has acquired a new building to expand its high-containment manufacturing and development operations.

Custom Pharma Services, a contract development and manufacturing (CDMO) organization, announced on Sept. 20, 2016 that it has acquired a new building to expand its high-containment manufacturing and development operations.

The new facility, the Custom Pharmaceutical Innovation Centre, is co-located on the Fairway Trading Estate in Brighton, adjacent to the company’s existing packaging and warehousing operations. Acquisition of this site will allow Custom Pharma Services to increase its capacity for clinical and product development of highly potent molecules and advance its commercial manufacturing and high-containment capabilities.

Custom Pharma Services will be exhibiting at CPhI Worldwide in Barcelona, Spain, Oct. 4–6, 2016, at booth 3B48. The CDMO will showcase how it takes compounds from clinical and product development stages to commercialization. 

Source: Custom Pharma Services 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content